High-Flow Nasal Cannula Combined with Prone Positioning as an Intubation Alternative in Covid-19: A Case Report and Review of the Literature
Acta Clinica Croatica
; 61(4):707-710, 2022.
Artículo
en Inglés
| Web of Science | ID: covidwho-20243122
ABSTRACT
The use of high-flow nasal cannula (HFNC) in COVID-19 patients is a contro-versial topic due to the benefits and risks which may occur in patients and healthcare workers. The goal of this treatment modality is potential avoidance of invasive mechanical ventilation, but generation of aerosol and increased healthcare professional infection risk must be considered. We present a case of a SARS-CoV-2-positive 71-year-old male with acute hypoxemic respiratory failure, who was success-fully treated with HFNC combined with prone positioning. Furthermore, we discuss recent literature concerning potential issues of HFNC treatment in COVID-19 patients.
Texto completo:
Disponible
Colección:
Bases de datos de organismos internacionales
Base de datos:
Web of Science
Tipo de estudio:
Reporte de caso
/
Estudio pronóstico
Idioma:
Inglés
Revista:
Acta Clinica Croatica
Año:
2022
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS